Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Low-dose bleomycin lung.

K S Wilson, A Worth, A G Richards

    Medical and Pediatric Oncology
    |January 1, 1982
    PubMed
    Summary
    This summary is machine-generated.

    Bleomycin chemotherapy can cause lung toxicity in lymphoma patients, presenting as fever and breathlessness. Prompt diagnosis and corticosteroid treatment (prednisone) can reverse these adverse pulmonary effects.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Hypomorphic RAG deficiency: impact of disease burden on survival and thymic recovery argues for early diagnosis and HSCT.

    Blood·2022
    Same author

    Calcaneotibial screws for immobilisation of the tarsocrural joint of dogs in extension: effect of the angle of screw placement on the force to failure in a canine cadaveric model.

    New Zealand veterinary journal·2021
    Same author

    Next generation physiologically based kinetic (NG-PBK) models in support of regulatory decision making.

    Computational toxicology (Amsterdam, Netherlands)·2019
    Same author

    Physiologically based mathematical models of nanomaterials for regulatory toxicology: A review.

    Computational toxicology (Amsterdam, Netherlands)·2019
    Same author

    Computational models for the assessment of manufactured nanomaterials: Development of model reporting standards and mapping of the model landscape.

    Computational toxicology (Amsterdam, Netherlands)·2019
    Same author

    An evaluation of the implementation of a parent-led, games-based physical activity intervention: the Active Play at Home quasi-randomized trial.

    Health education research·2018
    Same journal

    Kaposiform hemangioendothelioma and therapy with interferon-alpha.

    Medical and pediatric oncology·2003
    Same journal

    Importance of informed consent in offering to return research results to research participants.

    Medical and pediatric oncology·2003
    Same journal

    Tumor lysis syndrome and neuroblastoma.

    Medical and pediatric oncology·2003
    Same journal

    High incidence of brain tumors of childhood in Hungary between 1989 and 2001.

    Medical and pediatric oncology·2003
    Same journal

    Surviving childhood cancer: what next? Issues under consideration at the After Completion of Therapy (ACT) clinic in India.

    Medical and pediatric oncology·2003
    Same journal

    Local control in childhood extremity sarcomas: salvaging limbs and sparing function.

    Medical and pediatric oncology·2003
    See all related articles

    Area of Science:

    • Oncology
    • Pulmonary Medicine
    • Toxicology

    Background:

    • Retroperitoneal diffuse histiocytic lymphoma requires combination chemotherapy.
    • Bleomycin is a chemotherapeutic agent used in lymphoma treatment.

    Observation:

    • A patient receiving bleomycin developed acute breathlessness and fever.
    • Pulmonary function tests showed impairment, and gallium scans indicated diffuse lung uptake.
    • Initial chest X-rays were normal, but later films showed interstitial infiltrates.

    Findings:

    • Histologic examination confirmed bleomycin-induced lung toxicity.
    • Discontinuation of bleomycin and initiation of prednisone treatment led to clinical improvement.

    Implications:

    Related Experiment Videos

    • This case highlights the potential for severe pulmonary toxicity from bleomycin.
    • Early recognition and corticosteroid therapy are crucial for managing bleomycin-induced lung injury.
    • Awareness of bleomycin's pulmonary side effects is essential in lymphoma patient management.